BriaCell Gains After Update on Late-stage Trial for Lead Asset
Express News | Briacell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
Express News | HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target
Express News | Briacell Therapeutics Announces $5 Million Offering
BriaCell Therapeutics Announces $5 Million Offering
BriaCell Dips Despite Promising Mid-stage Data for Breast Cancer Therapy
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
Express News | Briacell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient With “Eye-Bulging” Tumor
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient With "Eye-Bulging" Tumor
Express News | Briacell Therapeutics Corp : H.c. Wainwright Cuts Target Price to $15 From $18
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
Express News | Briacell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
BriaCell Therapeutics Shares Retreat From Earlier Surge After Stock Offering
Express News | HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target
Canada Net Change Percentage Gainers & Losers
Penny Stocks On the Move (CNEY, BCTX, FTCI, TANH, QH)
Express News | Briacell Therapeutics Announces $8.5 Million Offering
BriaCell Therapeutics Announces $8.5 Million Offering